Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation

The combination of a calcineurin inhibitor (cyclosporine [CSA] or tacrolimus [Tac]) and methotrexate (MTX) or mycophenolate mofetil (MMF) are widely used approaches to graft-versus-host disease (GVHD) prevention. There is limited and conflicting data, however, on the comparative effectiveness of MMF...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biol Blood Marrow Transplant
Asıl Yazarlar: Hamilton, Betty K., Liu, Ying, Hemmer, Michael T., Majhail, Navneet, Ringden, Olle, Kim, Dennis, Costa, Luciano, Stuart, Robert, Alousi, Amin, Pidala, Joseph A., Couriel, Daniel R., Aljurf, Mahmoud, Antin, Joseph H., Bredeson, Christopher, Cahn, Jean-Yves, Cairo, Mitchell, Choi, Sung Won, Dandoy, Christopher, Gale, Robert Peter, Gergis, Usama, Hematti, Peiman, Inamoto, Yoshihiro, Kamble, Rammurti T., MacMillan, Margaret, Marks, David I., Nemecek, Eneida, Nishihori, Taiga, Saad, Ayman, Savani, Bipin N., Schriber, Jeff, Seo, Sachiko, Socié, Gérard, Teshima, Takanori, Verdonck, Leo F., Waller, Edmund K., Wirk, Mona, Spellman, Stephen R., Arora, Mukta, Chhabra, Saurabh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039394/
https://ncbi.nlm.nih.gov/pubmed/31158502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.05.019
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller